Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AACR 2021 | Highlights from AACR 2021

Serena Nik-Zainal • 14 Apr 2021
AACR 2021
General

Serena Nik-Zainal, MD, PhD, University of Cambridge, Cambridge, UK, discusses key moments from the virtual American Association for Cancer Research (AACR) Annual meeting, and touches on the breadth of research evaluated in the meeting. This interview took place at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021.

Disclosures

Serena Nik-Zainal, MD, PhD, has participated in consultancy work for Artios Pharma Ltd, the AstraZeneca Breast Expert Panel and the Scottish Genomes Partnership; has received grants or research support from Cancer Research UK, the Dr Josef Steiner Foundation, NIHR Cambridge core, the Medical Research Council UK, Wellcome and the Basser Initiative Gray Foundation; is the co-founder of Mu Genomics; and has patent filings/publications on six mutational-signature-based algorithms for clinical classification.

More from Serena Nik-Zainal

3:37
Harnessing the value of mutational signatures in whole cancer genomes
Serena Nik-Zainal • 14 Apr 2021

Related Videos

1:56
Phase I trial of trastuzumab deruxtecan and neratinib in HER2-altered tumors
Haeseong Park • 8 Apr 2024
2:45
Remaining challenges in treating solid tumors with CAR-Treg therapy
Leonardo Ferreira • 8 Apr 2024
2:01
Engineering chimeric antigen receptor regulatory T cells for treating cancer
Leonardo Ferreira • 8 Apr 2024
0:59
What challenges are there in using CAR-T cells for solid tumors?
Leonardo Ferreira • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals